Evidence map›Paper›PMID 40143260›Full record

ArticleViruses2025

Multiple Respiratory Virus Detection in Acute Respiratory Infection Patients in Mie Prefecture, Japan, 2021-2023.

Yuriko Tomita, Hiyori Okura, Rika Mochizuki, Manami Negoro, Takuya Yano, Yusuke Kobayashi, Ikuyo Takayama, Kiyosu Taniguchi, Shinji Watanabe, Hideki Hasegawa

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuriko TomitaResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.ORCID 0009-0005-0143-2475
Hiyori OkuraResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Rika MochizukiResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Manami NegoroInstitute for Clinical Research, National Hospital Organization, Mie National Hospital, Tsu-shi 514-0125, Japan.ORCID 0000-0003-3225-3662
Takuya YanoMie Prefecture Health and Environment Research Institute, Yokkaichi 512-1211, Japan.
Yusuke KobayashiCenter for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.ORCID 0000-0002-4541-8318
Ikuyo TakayamaResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Kiyosu TaniguchiDepartment of Pediatrics, National Hospital Organization Mie National Hospital, Tsu-shi 514-0125, Japan.ORCID 0000-0003-4584-6168
Shinji WatanabeResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Hideki HasegawaResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.

Funding

a Grant-in-Aid for Emerging and Reemerging Infectious Diseases and Immunization from the Ministry of Health, Labour, and Welfare, Japan no. JPMH21HA2003
6 · The paper itself

Abstract

The Coronavirus disease 2019 (COVID-19) pandemic significantly impacted the circulation patterns of respiratory viruses worldwide. To better understand viral circulation patterns during the transition from pandemic to endemic phase, we conducted comprehensive respiratory virus surveillance in Mie Prefecture, Japan, during 2021-2023, coinciding with the Delta-to-Omicron transition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We collected respiratory specimens from acute respiratory infection patients in medical institutions, detecting 19 respiratory viruses using real-time PCR in 1573 valid samples out of 1605 specimens. Demographic and clinical data were available for some specimens. SARS-CoV-2 Omicron strains showed a peak positivity of 15-25% during the epidemic, while respiratory syncytial virus and human rhinovirus/enterovirus exhibited one to two annual epidemic peaks up to 57%, and human adenovirus maintained a positivity rate of 5-20% throughout the year. Age-dependent analysis revealed the significant detection of multiple viruses, particularly in children under 2 years, with up to six viruses detected simultaneously in those under 5 years. Our findings demonstrate varied respiratory virus prevalence patterns, with some viruses remaining active during the Omicron epidemic, suggesting its limited impact on other viruses. This comprehensive approach should enhance the understanding of respiratory virus epidemic dynamics and inform public health strategies.

Indexed as

COVID-19Respiratory Tract InfectionsVirusesAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantInfant, NewbornJapanMaleMiddle AgedARI surveillanceCOVID-19multiple virus infection

Identifiers

PMID40143260
PMCPMC11945925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.